Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
"Generating flesh" is a functional therapeutic property primarily described in Traditional Chinese Medicine (TCM) as "Sheng Ji," rather than a specific molecular target such as a protein or receptor [1][4]. It refers to the physiological process of promoting wound healing, stimulating the growth of granulation tissue, and regenerating soft tissues (muscle and skin) in cases of chronic sores, ulcers, or non-healing wounds [4][5]. This multifaceted biological process involves the activation of multiple signaling pathways, including PI3K/Akt and MAPK, and the upregulation of various endogenous growth factors like VEGF and TGF-beta to facilitate fibroblast proliferation and collagen synthesis [1]. Because it describes a broad therapeutic outcome or macroscopic biological action rather than a discrete molecular entity, it is not classified as a therapeutic target in modern pharmacology [1]. Research into agents with this property focuses on their ability to accelerate tissue repair and improve the healing environment of damaged surfaces [5].
Promotion of wound closure and tissue repair via the induction of granulation tissue formation, collagen deposition, and enhancement of regional blood circulation, often through the activation of growth factor signaling pathways [1][4][5].
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Generating flesh.